Astrea Pharma

CDMO

In 2022, Groupe Chevrillon invested in Astrea Pharma, a newly formed CDMO, focused on finished doses and solid forms. Astrea Pharma’s first production site is located in Fontaine-lès-Dijon (France).

https://www.astreapharma.com/

Astrea Pharma
4954d7_3fe51aeaa9ee4737a57665bbf0f97676_mv2
Date de création : 2022
Chiffre d’affaires : n.a.
Implantation : Paris
Date de prise de participation : 2022